Huadong Medicine Co., Ltd
Huadong Medicine Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1993, the company has established itself as a leader in the development, manufacturing, and distribution of high-quality pharmaceutical products. Specialising in innovative medicines, Huadong Medicine focuses on areas such as oncology, cardiovascular health, and central nervous system disorders. Their commitment to research and development has led to the creation of unique formulations that address unmet medical needs, setting them apart in a competitive market. With a strong market position, Huadong Medicine has achieved significant milestones, including numerous product approvals and partnerships that enhance its global reach. The company’s dedication to quality and innovation continues to drive its success in the ever-evolving healthcare landscape.
DitchCarbon Score
How does Huadong Medicine Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Huadong Medicine Co., Ltd's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Huadong Medicine Co., Ltd's reported carbon emissions
Huadong Medicine Co., Ltd, headquartered in China (CN), currently does not have available carbon emissions data for the most recent year, nor does it report any specific reduction targets or climate commitments. The company has not disclosed any initiatives related to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no specific figures or scopes of emissions (Scope 1, 2, or 3) to report. In the absence of concrete emissions data or reduction initiatives, it is important to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and climate action. This trend often includes setting ambitious targets for reducing greenhouse gas emissions and improving energy efficiency. However, without specific commitments or data from Huadong Medicine Co., Ltd, it is unclear how the company aligns with these industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Huadong Medicine Co., Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
